Key facts
- This page summarizes David M. Stack's Form 4 filing for Pacira BioSciences, Inc. (PCRX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 13 Jan 2022, 15:11.
David M. Stack - 11 Jan 2022 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)
- Reporting relationship
- CEO and Chairman, Director
- Issuer ticker
- PCRX
- Reported as of
- 11 Jan 2022
- Net transaction value
- +$162,150
- SEC form
- 4
- Accepted by SEC
- 13 Jan 2022, 15:11:37 UTC
- Prior SEC filing
- 18 Nov 2021
- Next SEC filing
- 27 Jan 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kristen Williams, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David M. Stack filed Form 4 for Pacira BioSciences, Inc. (PCRX) on 13 Jan 2022.
Change
- Previous filing in this sequence was filed on 18 Nov 2021.
- Current net transaction value: +$162,150.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PCRX
transaction
Common Stock
Options Exercise
- Transaction value
- $162,150
- Shares
- +15,000
- Change %
- +16%
- Price
- $10.81
- Shares after
- 109,374
- Date
- 11 Jan 2022
- Ownership
- Direct
- Footnotes
- F1
PCRX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 97,273
- Date
- 11 Jan 2022
- Ownership
- By Three Colleens Investment, LLC
- Footnotes
- F2
PCRX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 18,596
- Date
- 11 Jan 2022
- Ownership
- By Stack Schroon Mohawk FLP
- Footnotes
- F2
PCRX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 315
- Date
- 11 Jan 2022
- Ownership
- LCK Investment LLC
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PCRX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -15,000
- Change %
- -20%
- Price
- $0.000000
- Shares after
- 58,670
- Date
- 11 Jan 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,000
- Exercise price
- $10.81
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Includes 289 shares of common stock acquired under the issuer's employee stock purchase plan in December 2021.
Footnote F2
Mr. Stack and his wife are the owners of each of Three Colleens Investment, LLC and LCK Investment LLC. Mr. Stack is the general partner of Stack Schroon Mohawk FLP.
Footnote F3
The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.